Markets

Alignment with Large and Dynamic Segments of Cancer Diagnostics

Market Segment

2024

CAGR

Prostate Cancer Diagnostics

Scope includes preliminary and confirmatory testing, ultra sound based diagnostics as well as molecular diagnostics

$4.1Bn ¹

13% ¹

Oncology Companion Diagnostics

Scope includes Immunohistochemistry and next-generation sequencing, multiple cancer type

$3.2Bn ¹

13% ¹

Oncology Molecular Diagnostics

Scope includes instruments and reagents, multiple cancer and molecule type

$3.7Bn ²

13% ²

Main Drivers

Increasing prevalence of cancers due to the growing geriatric population and changing lifestyles
Progress in cancer detection and patient awareness
Technological advancements in imaging, sequencing
Drug and diagnostics co-development models
Personalized Medicine
Government initiatives